DiSNEP: a Disease-Specific gene Network Enhancement to improve Prioritizing candidate disease genes
暂无分享,去创建一个
[1] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[2] Russ B. Altman,et al. Missing value estimation methods for DNA microarrays , 2001, Bioinform..
[3] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[4] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[5] J. Franklyn,et al. Expression of fibroblast growth factors in thyroid cancer. , 1995, The Journal of clinical endocrinology and metabolism.
[6] T. Kipps,et al. ATM Mutations in Cancer: Therapeutic Implications , 2016, Molecular Cancer Therapeutics.
[7] Wei Zheng,et al. dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks , 2011, Bioinform..
[8] Benno Schwikowski,et al. Network-based analysis of omics data: the LEAN method , 2016, Bioinform..
[9] Michelle Giglio,et al. Human Disease Ontology 2018 update: classification, content and workflow expansion , 2018, Nucleic Acids Res..
[10] M. Probst-Kepper,et al. CXCR4/CXCL12 expression and signalling in kidney cancer , 2002, British Journal of Cancer.
[11] L. Milanesi,et al. Network diffusion-based analysis of high-throughput data for the detection of differentially enriched modules , 2016, Scientific Reports.
[12] Huiling Li,et al. Upregulation of Tyrosine Kinase FYN in Human Thyroid Carcinoma: Role in Modulating Tumor Cell Proliferation, Invasion, and Migration. , 2017, Cancer biotherapy & radiopharmaceuticals.
[13] M. Xing,et al. Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer , 2016, BMC Medicine.
[14] F. Sanz,et al. The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..
[15] R. Koenig,et al. Pax-8–PPAR-γ fusion protein in thyroid carcinoma , 2014, Nature Reviews Endocrinology.
[16] Ralf Herwig,et al. Analyzing and interpreting genome data at the network level with ConsensusPathDB , 2016, Nature Protocols.
[17] G. Mills,et al. The PI3K/AKT Pathway and Renal Cell Carcinoma. , 2015, Journal of genetics and genomics = Yi chuan xue bao.
[18] Y. Moreau,et al. Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.
[19] Erik L. L. Sonnhammer,et al. MaxLink: network-based prioritization of genes tightly linked to a disease seed set , 2014, Bioinform..
[20] Ruth Pidsley,et al. A data-driven approach to preprocessing Illumina 450K methylation array data , 2013, BMC Genomics.
[21] Andrew M. Gross,et al. Network-based stratification of tumor mutations , 2013, Nature Methods.
[22] F. Rojo,et al. Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy , 2014, British Journal of Cancer.
[23] Xin Ma,et al. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis , 2015, Scientific Reports.
[24] Fei Wang,et al. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion , 2016, Tumor Biology.
[25] Andrew E. Teschendorff,et al. Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development , 2013, PLoS medicine.
[26] Sunmo Yang,et al. HumanNet v2: human gene networks for disease research , 2018, Nucleic Acids Res..
[27] R. Myers,et al. Candidate-gene approaches for studying complex genetic traits: practical considerations , 2002, Nature Reviews Genetics.
[28] F. Jasmine,et al. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips , 2013, Epigenetics.
[29] Jon C. Aster,et al. Network analysis of gene essentiality in functional genomics experiments , 2015, Genome Biology.
[30] E. Marcotte,et al. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. , 2011, Genome research.
[31] Wei Zhang,et al. Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. , 2018, Cell systems.
[32] David W. Johnson,et al. The emerging role of nuclear factor kappa B in renal cell carcinoma. , 2011, The international journal of biochemistry & cell biology.
[33] C. Cole,et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers , 2018, Nature Reviews Cancer.
[34] Jung Hun Song,et al. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases. , 2004, Molecular endocrinology.
[35] Shuigeng Zhou,et al. NEpiC: a network-assisted algorithm for epigenetic studies using mean and variance combined signals , 2016, Nucleic acids research.
[36] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[37] M. Boyd,et al. p53 and MDM2 in renal cell carcinoma , 2010, Cancer.
[38] M. Santoro,et al. Mutation of the PIK3CA gene in anaplastic thyroid cancer. , 2005, Cancer research.
[39] Daniel S. Himmelstein,et al. Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.
[40] Xiaoyan Zhou,et al. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer , 2016, International journal of oncology.
[41] The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer , 2018, BMC cancer.
[42] Hyunjung Shin,et al. Disease gene identification based on generic and disease-specific genome networks , 2018, Bioinform..
[43] Meng Zhang,et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway , 2015, Scientific Reports.
[44] Y. Okada,et al. Expression of TNF‐α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas , 2015, International journal of cancer.
[45] Zhe Zhang,et al. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells , 2013, Tumor Biology.
[46] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.